This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.


29Jan 2019

Back to News overview

Emile Voest, Anastassis Perrakis en Jannie Borst join Oncode

Three group leaders and their research groups from the Netherlands Cancer Institute join Oncode Institute per 2019. A selection committee of (inter)national experts selected  19 researchers from 160 applicants. With over 800 cancer researchers the Oncode team is now complete.

Medical director, medical oncologist and scientist Emile Voest aims to answer questions such as: how are tumor cells recognized by the immune system? And how do they escape? Group leader Anastassis (Tassos) Perrakis of the Biochemistry division investigates macromolecular structures (large molecules), in order to eventually translate basic research into new therapies. Group leader and head of the division Tumor Biology & Immunology Jannie Borst investigates, among other things, how cytotoxic T-cells fight tumors.


Share this page